✦ LIBER ✦

Long-Term Outcomes by Clopidogrel Duration and Stent Type in a Diabetic Population With De Novo Coronary Artery Lesions

✍ Scribed by Somjot S. Brar; John Kim; Simerjeet K. Brar; Ray Zadegan; Michael Ree; In-Lu A. Liu; Prakash Mansukhani; Vicken Aharonian; Ric Hyett; Albert Yuh-Jer Shen

Book ID: 119267384
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 839 KB
Volume: 51
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.01.063

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AS-127: Long-Term Clinical Outcomes afte

AS-127: Long-Term Clinical Outcomes after Intravascular Brachytherapy for In-Stent Restenosis and De Novo Coronary Artery Lesions in Percutaneous Coronary Intervention

✍ Hee Hwa Ho; On Hing Kwok; Man Hong Jim; Chung Wah Siu; Wing Hing Chow 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

TCT-279: Long Term Outcome After PCI Usi

TCT-279: Long Term Outcome After PCI Using Single Or Double Stenting In Diabetic Patients With De Novo Coronary Bifurcation Lesions - Results From A Large Single Center Registry

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Impact of sirolimus-eluting stents on ou

Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

✍ I. Moussa; M.B. Leon; D.S. Baim 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long-term clinical benefit of drug-eluti

Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: Results from a real-world multicenter registry

✍ Davide Capodanno; Maria Elena Di Salvo; Tullio Palmerini; Imad Sheiban; Massimo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB 👁 3 views

Five-year long-term clinical follow-up o

Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: The SPIRIT FIRST trial

✍ Marcus Wiemer; Patrick W. Serruys; Karine Miquel-Hebert; Franz-Josef Neumann; Ja 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Late-Term Clinical Outcomes With Zotarol

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

✍ David E. Kandzari; Laura Mauri; Jeffrey J. Popma; Mark A. Turco; Paul A. Gurbel; 📂 Article 📅 2011 🏛 American College of Cardiology 🌐 English ⚖ 704 KB